When will sotoraxibu be launched in China?
The launch date of a drug is usually determined jointly by the pharmaceutical company and regulatory agencies and may vary by country, region and market. To obtain the latest information, it is recommended to check announcements from the National Medical Products Administration of China (NMPA), statements from pharmaceutical companies, or contact medical professionals. The original drug of sotoraxibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotolasibu through overseas channels. The price of the original research version of sotorasibu in Hong Kong, China, is 120mg*240 tablets, which is around 8 million. The price of the European version of the original research drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)